PERKINELMER INC. SHARES DL 1 - 500 Beiträge pro Seite
eröffnet am 14.10.03 19:13:00 von
neuester Beitrag 05.01.21 15:55:40 von
neuester Beitrag 05.01.21 15:55:40 von
Beiträge: 9
ID: 785.957
ID: 785.957
Aufrufe heute: 0
Gesamt: 1.173
Gesamt: 1.173
Aktive User: 0
ISIN: US7140461093 · WKN: 850943 · Symbol: PKN
94,30
EUR
+0,06 %
+0,06 EUR
Letzter Kurs 08:57:01 Tradegate
Neuigkeiten
29.04.24 · Business Wire (engl.)  |
25.04.24 · Business Wire (engl.) |
25.04.24 · Business Wire (engl.) |
24.04.24 · Business Wire (engl.) |
15.04.24 · Business Wire (engl.) |
Werte aus der Branche Sonstige Technologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,8855 | +151,57 | |
| 3,0200 | +34,22 | |
| 10,420 | +14,63 | |
| 1,3900 | +13,01 | |
| 3,5700 | +11,21 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 98,50 | -8,80 | |
| 3,7100 | -9,29 | |
| 75,76 | -10,68 | |
| 2,4000 | -10,85 | |
| 1,4400 | -28,00 |
Feedback
Profile
PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers` needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index.
PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers` needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index.
PerkinElmer Third Quarter Earnings and Conference Call Notification
BOSTON--(BUSINESS WIRE)--Oct. 13, 2003--PerkinElmer, Inc. (NYSE:PKI) announced today that at the close of business on Wednesday, October 22, 2003, the Company will release third quarter 2003 results. The Company will hold a conference call to discuss the results the following day, October 23, 2003 at 10:00 a.m. ET. Gregory L. Summe, chairman and chief executive officer, and Robert F. Friel, senior vice president and chief financial officer, will host the conference
BOSTON--(BUSINESS WIRE)--Oct. 13, 2003--PerkinElmer, Inc. (NYSE:PKI) announced today that at the close of business on Wednesday, October 22, 2003, the Company will release third quarter 2003 results. The Company will hold a conference call to discuss the results the following day, October 23, 2003 at 10:00 a.m. ET. Gregory L. Summe, chairman and chief executive officer, and Robert F. Friel, senior vice president and chief financial officer, will host the conference
PerkinElmer, Inc. is a global technology leader providing products and services to customers in health sciences and other advanced technology markets that require innovation, precision and reliability.
Facts about PerkinElmer
$1.5B Revenue
Operating in 125 countries
10,700 employees
Member S&P 500 Index
Business Units
PerkinElmer, Inc. is focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of is customers` needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company is a leading provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets. We design, manufacture, market and service products and systems within three business units
Facts about PerkinElmer
$1.5B Revenue
Operating in 125 countries
10,700 employees
Member S&P 500 Index
Business Units
PerkinElmer, Inc. is focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of is customers` needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company is a leading provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets. We design, manufacture, market and service products and systems within three business units
Trading Spotlight
PerkinElmer Expands Screening and Drug Discovery Relationship with AstraZeneca
BOSTON, Apr 6, 2004 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a leading
provider of drug discovery, life science research and analytical solutions,
today announced it has been awarded an expanded contract with AstraZeneca R&D
Montreal. Under the terms of the agreement, PerkinElmer`s High Throughput
Screening (HTS) assay technologies will be used in expanded projects that test
AstraZeneca`s compounds against a defined selection of G protein-coupled
receptors (GPCRs), a major area of disease targets currently under study.
BOSTON, Apr 6, 2004 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a leading
provider of drug discovery, life science research and analytical solutions,
today announced it has been awarded an expanded contract with AstraZeneca R&D
Montreal. Under the terms of the agreement, PerkinElmer`s High Throughput
Screening (HTS) assay technologies will be used in expanded projects that test
AstraZeneca`s compounds against a defined selection of G protein-coupled
receptors (GPCRs), a major area of disease targets currently under study.
PerkinElmer and Labindia Launch Direct Sales and Service Operation in India; Partnership Highlights Investment in India`s Growing Life and Analytical Sciences Market
BOSTON, Apr 26, 2004 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a
leading provider of drug discovery, life science research, and analytical
solutions, and Labindia Instruments Pvt. Ltd., India`s leading lab service and
marketing organization, today jointly announced the launch of PerkinElmer India
Pvt. Ltd., a direct sales, service and marketing operation targeting India`s
thriving life science and analytical instrumentation markets. The partnership
provides a strong growth opportunity for PerkinElmer and underscores the
company`s commitment to customers in the region.
PerkinElmer will hold a majority interest in the joint venture, which will be
headquartered in Thane, India, with demo facilities and sales offices in Mumbai,
Thane, New Delhi, Chennai, Baroda, Pune, Hyderabad, Lucknow, Kolkatta and
Bangalore. PerkinElmer India will employ 180 people dedicated to direct sales,
service, technical support and administration.
"India represents a key growth market for a number of PerkinElmer businesses,
including biopharma, environmental and chemical, and genetic screening," said
Peter Coggins, Ph.D., president, PerkinElmer Life and Analytical Sciences. "We
are pleased to be working with Labindia to bring the full range of our Life and
Analytical Sciences product and service portfolio to India`s rapidly expanding
community of scientists and researchers."
BOSTON, Apr 26, 2004 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a
leading provider of drug discovery, life science research, and analytical
solutions, and Labindia Instruments Pvt. Ltd., India`s leading lab service and
marketing organization, today jointly announced the launch of PerkinElmer India
Pvt. Ltd., a direct sales, service and marketing operation targeting India`s
thriving life science and analytical instrumentation markets. The partnership
provides a strong growth opportunity for PerkinElmer and underscores the
company`s commitment to customers in the region.
PerkinElmer will hold a majority interest in the joint venture, which will be
headquartered in Thane, India, with demo facilities and sales offices in Mumbai,
Thane, New Delhi, Chennai, Baroda, Pune, Hyderabad, Lucknow, Kolkatta and
Bangalore. PerkinElmer India will employ 180 people dedicated to direct sales,
service, technical support and administration.
"India represents a key growth market for a number of PerkinElmer businesses,
including biopharma, environmental and chemical, and genetic screening," said
Peter Coggins, Ph.D., president, PerkinElmer Life and Analytical Sciences. "We
are pleased to be working with Labindia to bring the full range of our Life and
Analytical Sciences product and service portfolio to India`s rapidly expanding
community of scientists and researchers."
.
!
Dieser Beitrag wurde von CloudMOD moderiert. Grund: Löschung auf Wunsch des Users
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| +0,64 | |
| +0,83 | |
| +1,92 | |
| +0,21 | |
| 0,00 | |
| +3,29 | |
| +1,63 | |
| -3,99 | |
| +3,02 | |
| -1,51 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 240 | ||
| 95 | ||
| 73 | ||
| 70 | ||
| 57 | ||
| 50 | ||
| 48 | ||
| 39 | ||
| 38 | ||
| 32 |
